20 related articles for article (PubMed ID: 10846570)
1. Comparative immunohistochemical studies of p53 and proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions in pancreatic duct cell carcinomas.
Suzuki T; Takano Y
Jpn J Cancer Res; 1993 Oct; 84(10):1072-7. PubMed ID: 7901190
[TBL] [Abstract][Full Text] [Related]
2. Bromodeoxyuridine labeling index as an indicator of early tumor response to preoperative radiotherapy in patients with rectal cancer.
Gasinska A; Skolyszewski J; Popiela T; Richter P; Darasz Z; Nowak K; Niemiec J; Biesaga B; Adamczyk A; Bucki K; Malecki K; Reinfuss M; Kowalska T
J Gastrointest Surg; 2007 Apr; 11(4):520-8. PubMed ID: 17436139
[TBL] [Abstract][Full Text] [Related]
3. Proliferating cell nuclear antigen (PCNA) overexpression and microvessel density predict survival in the urinary bladder carcinoma.
El-kott AF; El-baz MA; Mokhtar AA
Int Urol Nephrol; 2006; 38(2):237-42. PubMed ID: 16868689
[TBL] [Abstract][Full Text] [Related]
4. Human colorectal cancers with an intact p16/cyclin D1/pRb pathway have up-regulated p16 expression and decreased proliferation in small invasive tumor clusters.
Palmqvist R; Rutegârd JN; Bozoky B; Landberg G; Stenling R
Am J Pathol; 2000 Dec; 157(6):1947-53. PubMed ID: 11106567
[TBL] [Abstract][Full Text] [Related]
5. Low tumour cell proliferation at the invasive margin is associated with a poor prognosis in Dukes' stage B colorectal cancers.
Palmqvist R; Sellberg P; Oberg A; Tavelin B; Rutegård JN; Stenling R
Br J Cancer; 1999 Feb; 79(3-4):577-81. PubMed ID: 10027333
[TBL] [Abstract][Full Text] [Related]
6. Systematic heterogeneity and prognostic significance of cell proliferation in colorectal cancer.
Palmqvist R; Oberg A; Bergström C; Rutegård JN; Zackrisson B; Stenling R
Br J Cancer; 1998 Mar; 77(6):917-25. PubMed ID: 9528835
[TBL] [Abstract][Full Text] [Related]
7. Differences in AgNOR quantity between colorectal cancer and corresponding metastases: are they useful for prognostic purposes?
Giuffrè G; Barresi G; Speciale G; Sarnelli R; Gioffrè Florio MA; Tuccari G
Eur J Histochem; 1997; 41(2):111-8. PubMed ID: 9271703
[TBL] [Abstract][Full Text] [Related]
8. Proliferative, infiltrative, and metastatic activities in colorectal tumors assessed by MIB-1 antibody.
Ishida H; Sadahiro S; Suzuki T; Ishikawa K; Kamijo A; Tajima T; Makuuchi H; Murayama C
Oncol Rep; 2003; 10(6):1741-5. PubMed ID: 14534689
[TBL] [Abstract][Full Text] [Related]
9. Proliferating cell nuclear antigen expression correlates with the metastatic potential of submucosal invasive colorectal carcinoma.
Tanaka S; Haruma K; Tatsuta S; Hiraga Y; Teixeira CR; Shimamoto F; Yoshihara M; Sumii K; Kajiyama G
Oncology; 1995; 52(2):134-9. PubMed ID: 7854773
[TBL] [Abstract][Full Text] [Related]
10. The prognostic importance of the nucleolar organizer region (AgNOR), Ki-67 and proliferating cell nuclear antigen (PCNA) in primary nonurachal bladder adenocarcinoma.
Ozdemir BH; Ozdemir OG; Sertçelik A
APMIS; 2001 Jun; 109(6):428-34. PubMed ID: 11506474
[TBL] [Abstract][Full Text] [Related]
11. Stereologic estimates of volume-weighted mean nuclear volume in colorectal adenocarcinoma: correlation with histologic grading, Dukes' staging, cell proliferation activity and p53 protein expression.
Martín R; Nieto S; Santamaría L
Gen Diagn Pathol; 1997 Jul; 143(1):29-38. PubMed ID: 9269906
[TBL] [Abstract][Full Text] [Related]
12. Comparison of proliferative activities and metastases between two subtypes classified at the deeply infiltrating sites of colorectal moderately differentiated adenocarcinomas.
Taniyama K; Sasaki N; Wada S; Sasaki M; Miyoshi N; Nakai H; Kodama S; Nakatsuka H; Tahara E
Pathol Int; 1996 Mar; 46(3):195-203. PubMed ID: 10846570
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
